Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor of NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can quickly elevate NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4][6]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with no known adverse reactions and the highest conversion efficiency [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, making NMN supplements, which can provide up to 300 times the dietary intake, more effective for achieving beneficial doses [8]. Synthesis Technology - The NMN synthesis process has shifted from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in full enzymatic synthesis and patenting technologies to create competitive advantages [12]. Market Trends and Applications - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. - The NMN market in China is expected to exceed 3 billion yuan by 2025, driven by regulatory changes and new applications [28]. Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border platforms accounting for 60%-70% of market share [35]. Certification and Compliance - The "blue hat" certification for health supplements in China represents the highest standard for NMN products, with strict approval processes impacting market dynamics [37]. Future Prospects - The NMN industry is poised for growth, with increasing demand driven by an aging population and younger consumers seeking anti-aging solutions [19][21]. - Technological advancements in synthesis, quality control, and delivery methods are expected to enhance market growth and product efficacy [21][22]. Challenges - The NMN industry faces challenges such as regulatory hurdles, market education, and the need for scientific validation to support claims [61][63].

Core Insights - The opening of Hainan's zero-tariff policy marks a significant shift in trade dynamics, with the first day seeing a total value of 360 million yuan in goods entering the island, indicating a new era for the region [1] - Japanese companies are weighing the benefits of relocating operations to Hainan to take advantage of tax incentives and reduced costs, despite facing challenges related to regulatory compliance and competition [3][4] Group 1: Economic Impact - The value of zero-tariff goods entering Hainan on the first day reached 360 million yuan, symbolizing the start of a new trade era [1] - The number of zero-tariff products has expanded from 1,900 to 6,600, increasing coverage from 20% to 74%, with an annual tax-free allowance of up to 100,000 yuan per person [3] - Logistics costs are significantly reduced, with fuel prices at Hainan's Yangpu Port being 8% lower than in Singapore, saving up to 240,000 yuan per refueling for large vessels [3] Group 2: Business Opportunities - Japanese companies are exploring the potential of relocating production to Hainan, with one chocolate factory owner estimating an 80% reduction in annual costs by moving operations [3] - The opening of the seventh freedom of the air allows Japanese goods to fly directly from Tokyo to Haikou, facilitating easier access to Southeast Asian markets [4] - Major Japanese firms like Takeda Pharmaceutical are investing heavily in Hainan, with plans to invest over 15 billion USD in three years and a partnership worth 11.4 billion USD for innovative drug development [9] Group 3: Challenges and Considerations - Japanese companies face regulatory hurdles, such as the requirement for a 30% value addition in Hainan to qualify for tax exemptions, which complicates their decision-making [4][6] - Concerns about core technology leakage and the need for comprehensive employee welfare and regulatory compliance are causing hesitation among Japanese firms [6] - The competitive landscape is shifting, with Japan's industrial electricity prices being 60% higher than those in Hainan, and a younger labor force in Hainan presenting a potential advantage [6] Group 4: Strategic Collaborations - A memorandum of cooperation was signed between Hainan's trade promotion agency and the Kansai Chinese Chamber of Commerce, focusing on green energy and healthcare as key collaboration areas [8] - Companies like Mitsubishi Corporation are establishing regional R&D centers in Hainan, while Mizuho Bank is creating a one-stop financial service platform for Japanese businesses [9] - Educational partnerships are forming, such as the joint establishment of a research center by Waseda University and Hainan University to support long-term talent development for Japanese firms [9]

Group 1 - Han Shu, a brand under Shangmei Co., reported an annual revenue of 5.591 billion yuan, with a year-on-year growth of 80.9% [4] - The brand's products, specifically the Han Shu Rich Tightening Essence Mask and the Han Shu Brightening Mask, were found to contain epidermal growth factor (EGF) at levels of 0.07 pg/g and 3.21 pg/g respectively, which violates quality standards [1][3] - EGF is primarily used in medical fields for treating burns and wounds, and its use in cosmetics is prohibited due to safety concerns related to skin absorption [2][3] Group 2 - As of the report, Han Shu's official flagship store has 9.26 million followers and annual sales exceeding 10 million units [3] - The products in question have been removed from the store, and customer service provided no further explanation regarding the detection of EGF [3]

Core Viewpoint - The official launch of the Hainan Free Trade Port's full island closure operation on December 18, 2025, presents both opportunities and challenges for Japanese companies, amid strained Sino-Japanese relations [1][9]. Group 1: Benefits for Japanese Companies - The zero-tariff policy will expand the range of imported goods to 6,600 tax items, covering 74% of product categories, significantly increasing from the previous 1,900 items [3]. - Japanese cosmetics company Shiseido can expect a cost reduction of 15% to 25% by directly importing raw materials to Hainan without tariffs [3]. - Logistics costs for Japanese companies are projected to decrease significantly, aiding supply chain integration in Southeast Asia, particularly for time-sensitive industries like pharmaceuticals and cold chain logistics [3]. - The annual duty-free shopping limit for individuals in Hainan is set at 100,000 yuan, with an expanded variety of products, allowing brands like SK-II and Lawson to benefit from the growing global duty-free market, which Hainan currently holds over 8% market share [3]. - The opening of the seventh freedom rights allows foreign airlines to operate directly in Hainan, reducing costs for Japanese airlines like Japan Airlines when transporting goods to Southeast Asia [3]. Group 2: Investment Trends - Japanese companies are increasingly attracted to Hainan's low tax rates, with corporate income tax capped at 15% and personal income tax also at 15%, enhancing the region's appeal for high-end talent [5]. - Mitsubishi Corporation has established a regional R&D center in Hainan, shifting investments from trade to high-value-added industries [5]. - The comprehensive cost reduction for Japanese firms is estimated at 8% to 10%, providing additional profit margins for the manufacturing sector [5]. - A memorandum of cooperation was signed between Hainan's trade promotion agency and the Kansai Chinese Chamber of Commerce, focusing on healthcare and trade investment [5]. - The establishment of a financial service platform by Mizuho Bank aims to support Japanese companies with one-stop services, indicating proactive measures despite some companies expressing caution [5][13]. Group 3: Challenges and Risks - Japanese companies face strict regulations requiring that imported goods processed in Hainan must achieve a value-added rate of at least 30% to qualify for zero tariffs, complicating logistics and potentially increasing costs [7]. - The ongoing tensions in Sino-Japanese relations, particularly statements from Japanese politician Sanae Takaichi regarding Taiwan, have raised concerns about potential retaliatory measures from China, affecting trade and tourism [9][11]. - The potential for increased diplomatic friction could lead to further restrictions on Japanese seafood imports and cultural exchanges, creating uncertainty for Japanese businesses considering investment in Hainan [9][11]. - Japanese companies are caught in a dilemma between the need to invest in Hainan to capture market share and the fear of domestic industry hollowing out, as they risk losing market presence to competitors like South Korea [15].

Group 1 - The report highlights the transition from "consumption upgrade" to "consumption stratification" in China, where consumers are increasingly seeking cost-effectiveness in traditional products while being willing to pay a premium for innovative and emotionally valuable goods [2][15][30] - The emotional consumption trend is driven by fast-paced lifestyles and mental health concerns, leading to increased demand for products that provide emotional comfort, such as trendy toys, skincare, and gourmet snacks [2][30][32] Group 2 - The Chinese trendy toy market is rapidly expanding, projected to grow from 22.9 billion yuan in 2020 to 76.3 billion yuan by 2024, with a CAGR of 35.11%, driven by rising disposable income and the popularity of emotional consumption [3][37] - The market is characterized by a fragmented structure, with the top five companies holding only 20.8% market share, indicating potential for consolidation and growth among companies with strong IP resources and extensive distribution channels [3][46][47] Group 3 - The gold and jewelry sector is shifting from channel-driven to product-driven dynamics, with high dividend yields providing defensive attributes amid rising gold prices, which have reached historical highs [4][51] - Despite a temporary decline in gold jewelry consumption due to high prices, companies with strong design and marketing capabilities are still achieving rapid growth [4][51] Group 4 - The cosmetics industry is witnessing a resurgence, particularly for domestic brands, which are gaining market share due to improved product quality and marketing strategies, especially during promotional events like "Double 11" [4][28] - Young consumers are increasingly accepting domestic beauty brands, leading to a potential rise in market share against foreign competitors [4][28]

Core Viewpoint - The breakthrough of "transdermal collagen" technology by Furuida Biological Co., under the brand Kemi, marks a significant advancement in the global cosmetics science arena, showcasing China's transition from application follower to principle definer in beauty technology [3][4][10]. Group 1: Event Overview - The 79th Annual Scientific Meeting of the Society of Cosmetic Chemists (SCC) was held in New York on December 16, 2025, celebrating the 80th anniversary of the SCC, which is a historic and influential academic platform in the cosmetics science field [5]. - The conference theme "Science Reimagined" indicates the ongoing transformation within the industry, with a focus on innovative technologies from Chinese enterprises [5][9]. Group 2: Technology Breakthrough - Kemi's report highlighted a 27.5 times increase in the permeability of large molecular collagen, addressing the long-standing challenge of low absorption rates in skincare applications [3][14]. - The technology utilizes a "transdermal engine" that integrates a short peptide sequence capable of penetrating cell membranes into the collagen gene, allowing the collagen to actively enter skin cells [12]. Group 3: Scientific Validation - The efficacy of the transdermal collagen was validated through rigorous scientific methods, including Raman spectroscopy, ensuring that the technology is grounded in real physiological conditions and consumer experiences [4][20]. - Clinical trials demonstrated that after 28 days of using the Kemi Recombined Collagen Anti-Wrinkle Essence, participants experienced a 17.16% reduction in crow's feet and a 23.24% reduction in frown lines, confirming the product's effectiveness [16]. Group 4: Market Impact - Kemi's products have achieved significant market success, with the "transdermal collagen essence" becoming a top-selling item shortly after launch, reflecting consumer demand for scientifically validated anti-aging products [21][23]. - The brand's positioning as a high-end product with a clear technological narrative has resulted in a customer price point significantly above the industry average, breaking the traditional price barriers for domestic brands [21][23]. Group 5: Future Implications - The success of Kemi at the SCC signifies a new phase for Chinese beauty technology, transitioning from product and ingredient output to technology solution output, showcasing the competitive edge of Chinese enterprises in global innovation [23][24]. - The global collagen market is expected to grow at a compound annual growth rate of over 40%, indicating a shift in competition towards a focus on bioactive design, intelligent delivery technology, and scientific efficacy validation [24].

Core Viewpoint - The company, Jiaheng Jiahua, is undergoing a potential change in control as notified by its controlling shareholder, Zeng Bensheng, which may lead to a change in the company's actual controller [1]. Company Summary - Jiaheng Jiahua is primarily engaged in the research, design, and production of daily chemical products (OEM/ODM) and plastic packaging containers, providing integrated services for cosmetics and household care products [3]. - The company's main products include skincare, hair care, perfumes, soaps, disinfectants, and hand sanitizers, with major clients including well-known companies such as Kefu, Beitaini, and Procter & Gamble [4]. Financial Performance - In the first three quarters of 2025, Jiaheng Jiahua reported revenue of 859.6 million yuan, representing a year-on-year growth of 24.42%, but incurred a net loss of 29.5 million yuan [4]. - The cosmetics industry showed signs of recovery in 2025, despite a slight decline in growth compared to the overall retail sales of consumer goods [4].

Group 1: Crybaby Exhibition - The "Letting Go... Holding On..." Crybaby exhibition, presented by Pop Mart and Molly Factory, officially opened on December 20, 2025, in Shanghai, marking Crybaby's first appearance in China and its largest exhibition to date [1] - The exhibition spans nearly 2,000 square meters, designed as a "soft world" that invites visitors to embark on an emotional journey centered around tears [1] - Key features include the "tear ball pool," which covers 864 square meters and connects three main pools, symbolizing a journey from overcoming obstacles to self-liberation [2] Group 2: Emotional Themes and Interactivity - The exhibition's design translates abstract emotions into tangible, interactive scenes, showcasing classic characters Crybaby, Crybunny, and Cryteddy [2] - Interactive elements such as finding "tear drop" lucky balls, lighting up emotional icons, and creating personalized Crybaby figures enhance the exploration and engagement of visitors [2]

Core Viewpoint - Amorepacific Group is implementing a voluntary retirement program to address the rapidly changing domestic and international business environment, marking the first such initiative since the pandemic-induced performance decline in December 2020 [1] Group 1: Voluntary Retirement Program - The voluntary retirement program targets employees with over 15 years of service in functional and offline sales departments, or those aged 45 and above who joined the company later [3] - The compensation for employees with over 20 years of service is equivalent to 42 months of basic salary, while those with 15 to 20 years of service and employees aged 45 and above will receive compensation calculated at 2 months of basic salary for each year worked [3] - In addition to compensation, the company will provide support services, including comprehensive health check benefits for departing employees and their spouses for two years post-retirement [3] Group 2: Financial Performance - Despite the challenges reflected in the voluntary retirement plan, Amorepacific Group reported growth in its third-quarter performance, achieving sales of 1.02 trillion KRW, a year-on-year increase of 4.1% [3] - The operating profit for the third quarter reached 919 billion KRW, representing a significant year-on-year growth of 41% [3]

一款为赛因诗婷舒缓特护喷雾，注册人/备案人为深圳市蕙尔瑞生物科技有限公司，生产企业为清远市英创生物科技有限公司，检出菌落总数为1.0×10⁴CF U/g（限值要求≤ 1000CFU/g）。另一款为EVM肌安舒润保湿喷雾，注册人/备案人为上海萧雅生物科技股份有限公司，生产企业为无锡市伙伴日化科技有限 公司，检出菌落总数为3.7×10⁴CF U/g（限值要求≤ 1000CFU/g）。 据赛因诗婷官网显示，深圳市蕙尔瑞生物科技有限公司创立于2005年，是一家专注于医疗科技美容的化妆品企业，依托于法国丹妮丝国际有限公司提供的技 术支持，而赛因诗婷为其推出的医美品牌。 12月22日，广东省药品监督管理局官网发布了化妆品抽样检验信息的通告，此次总计抽检了750批次化妆品，有16批次化妆品不符合规定。其中，两款喷雾 均因菌落总数超标导致不合格。 至于EVM，公开资料显示，其为上海萧雅生物科技股份有限公司于2018年创立的功能型护肤品牌。目前EVM线上旗舰店有精华、面霜、面膜、化妆水等多 款产品在售。 ...